Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Short Interest Down 5.6% in April

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was the target of a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 3,520,000 shares, a decline of 5.6% from the March 31st total of 3,730,000 shares. Approximately 3.9% of the company’s stock are sold short. Based on an average daily volume of 566,600 shares, the short-interest ratio is currently 6.2 days.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on ACHC shares. Stephens raised shares of Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price target for the company in a research report on Friday, January 5th. TheStreet upgraded shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research note on Monday, March 4th. Mizuho upped their target price on shares of Acadia Healthcare from $77.00 to $84.00 and gave the stock a “neutral” rating in a research report on Wednesday, March 6th. Royal Bank of Canada restated an “outperform” rating and set a $94.00 target price on shares of Acadia Healthcare in a research report on Monday, March 4th. Finally, TD Cowen upped their target price on shares of Acadia Healthcare from $86.00 to $101.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. Four analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $92.00.

Insider Transactions at Acadia Healthcare

In related news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the completion of the sale, the director now directly owns 46,074 shares of the company’s stock, valued at $3,934,258.86. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Corporate insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On Acadia Healthcare

Several institutional investors and hedge funds have recently modified their holdings of the company. Fifth Third Bancorp lifted its stake in shares of Acadia Healthcare by 25.5% during the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after buying an additional 136 shares during the period. Estate Counselors LLC raised its stake in Acadia Healthcare by 0.9% during the third quarter. Estate Counselors LLC now owns 16,410 shares of the company’s stock worth $1,154,000 after purchasing an additional 145 shares during the period. Tranquility Partners LLC raised its stake in Acadia Healthcare by 5.3% during the fourth quarter. Tranquility Partners LLC now owns 3,395 shares of the company’s stock worth $264,000 after purchasing an additional 170 shares during the period. Mackenzie Financial Corp raised its stake in Acadia Healthcare by 1.3% during the third quarter. Mackenzie Financial Corp now owns 15,737 shares of the company’s stock worth $1,063,000 after purchasing an additional 199 shares during the period. Finally, New York State Teachers Retirement System increased its position in shares of Acadia Healthcare by 0.3% in the first quarter. New York State Teachers Retirement System now owns 76,054 shares of the company’s stock worth $6,025,000 after acquiring an additional 200 shares in the last quarter.

Acadia Healthcare Stock Down 0.9 %

ACHC stock opened at $73.94 on Wednesday. The company’s 50 day simple moving average is $77.91 and its 200-day simple moving average is $77.73. The firm has a market capitalization of $6.83 billion, a PE ratio of -295.75, a P/E/G ratio of 2.17 and a beta of 1.31. Acadia Healthcare has a 12 month low of $66.49 and a 12 month high of $87.77. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.67 and a quick ratio of 0.67.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, February 28th. The company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.80 by $0.05. The business had revenue of $742.80 million for the quarter, compared to analyst estimates of $727.60 million. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The company’s quarterly revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the business earned $0.70 earnings per share. Equities analysts expect that Acadia Healthcare will post 3.57 earnings per share for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.